WYB
2,2'-[(2-chloro-5-cyano-1,3-phenylene)bis(azanediyl)]bis(oxoacetic acid)
Created: | 2022-10-24 |
Last modified: | 2023-10-31 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 27 |
Chiral Atom Count | 0 |
Bond Count | 27 |
Aromatic Bond Count | 6 |
Chemical Component Summary | |
---|---|
Name | 2,2'-[(2-chloro-5-cyano-1,3-phenylene)bis(azanediyl)]bis(oxoacetic acid) |
Synonyms | Lodoxamide |
Systematic Name (OpenEye OEToolkits) | 2-[[3-(carboxycarbonylamino)-2-chloranyl-5-cyano-phenyl]amino]-2-oxidanylidene-ethanoic acid |
Formula | C11 H6 Cl N3 O6 |
Molecular Weight | 311.635 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | Clc1c(cc(cc1NC(=O)C(=O)O)C#N)NC(=O)C(=O)O |
SMILES | CACTVS | 3.385 | OC(=O)C(=O)Nc1cc(cc(NC(=O)C(O)=O)c1Cl)C#N |
SMILES | OpenEye OEToolkits | 2.0.7 | c1c(cc(c(c1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N |
Canonical SMILES | CACTVS | 3.385 | OC(=O)C(=O)Nc1cc(cc(NC(=O)C(O)=O)c1Cl)C#N |
Canonical SMILES | OpenEye OEToolkits | 2.0.7 | c1c(cc(c(c1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N |
InChI | InChI | 1.06 | InChI=1S/C11H6ClN3O6/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21) |
InChIKey | InChI | 1.06 | RVGLGHVJXCETIO-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank ID | DB06794 |
---|---|
Name | Lodoxamide |
Groups | approved |
Description | Lodoxamide is a mast-cell stabilizer for topical administration into the eye. Mast-cell stabilizers, first one approved being cromolyn sodium, are used in treatment of ocular hypersensitivity reactions such as vernal conjunctivitis. These conditions often require treatment with anti-inflammatory medications such as ophthalmic NSAIDs or topical steroids which may cause systemic or toxic effects long-term. Although less effective than topical steroids at decreasing inflammation, mast-cell stabilizers offer another treatment option and exhibit minimal adverse effects. Lodoxamide is marketed under the brand name Alomide by Alcon. |
Synonyms |
|
Brand Names | Alomide |
Indication | Indicated in the treatment of the ocular disorders referred to by the terms vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis. |
Categories |
|
ATC-Code | S01GX05 |
CAS number | 53882-12-5 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 44564 |
ChEMBL | CHEMBL1201266 |
ChEBI | CHEBI:135333 |